REPLIGEN CORP (RGEN) › Capital ExpendituresREPLIGEN CORP (RGEN) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2010: $597.3K2011: $524.7K2012: $1.26M2013: $4.63M2014: $5.60M2015: $2.63M2016: $4.33M2017: $5.45M2018: $10.63M2019: $18.50M2020: $22.45M2021: $67.09M2022: $84.83M2023: $36.22M2024: $25.68M2025: $23.52M$23.52M2010Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$23.52M-8.4%2024$25.68M-29.1%2023$36.22M-57.3%2022$84.83M+26.4%2021$67.09M+198.8%2020$22.45M+21.4%2019$18.50M+74.0%2018$10.63M+95.0%2017$5.45M+26.1%2016$4.33M+64.6%2015$2.63M-53.1%2014$5.60M+20.9%2013$4.63M+266.8%2012$1.26M+140.8%2011$524.7K-12.2%2010$597.3K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share